<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>AG-013736 is an oral anti-<z:mpath ids='MPATH_177'>angiogenesis</z:mpath> agent with activity against a variety of receptor tyrosine kinases, including VEGFR-1, VEGFR-2, VEGFR-3, c-kit, and PDGFR-beta </plain></SENT>
<SENT sid="1" pm="."><plain>A phase 2 study was conducted in patients with poor prognosis <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">AML</z:e> or <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e> </plain></SENT>
<SENT sid="2" pm="."><plain>Twelve patients (six <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">AML</z:e>; six <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e>) were treated with AG-013736 at a dose of 10mg orally daily for a median of 56 days (range, 1-248 days) </plain></SENT>
<SENT sid="3" pm="."><plain>Median age was 80 years (range, 58-88 years) </plain></SENT>
<SENT sid="4" pm="."><plain>Grade 3 or 4 drug-related toxicities included <z:hpo ids='HP_0000822'>hypertension</z:hpo> (42%), mucositis (8%) and <z:hpo ids='HP_0002625'>deep venous thrombosis</z:hpo> (8%) </plain></SENT>
<SENT sid="5" pm="."><plain>No objective responses occurred; two patients with <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e> had stable disease for 8.3 and 6.2 months, respectively </plain></SENT>
<SENT sid="6" pm="."><plain>Bone marrow expression of VEGFR-1 and VEGFR-2 was observed in 11% and 0% of patients, respectively </plain></SENT>
<SENT sid="7" pm="."><plain>Sustained decreases in soluble VEGFR-2 plasma levels with concomitant elevation in plasma VEGF and placental growth factor levels were obtained during the course of therapy with AG-013736 </plain></SENT>
<SENT sid="8" pm="."><plain>AG-01736 had minimal biologic or clinical activity in this elderly patient population </plain></SENT>
</text></document>